Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir

Robert Douglas Bruce,Frederick L. Altice,David E. Moody,Gene D. Morse,Laurie Andrews,Shen-Nan Lin,Wenfang B. Fang,Qing Ma,Gerald Friedland

Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir

2010

Robert Douglas Bruce
Frederick L. Altice
David E. Moody
Gene D. Morse
Laurie Andrews
Shen-Nan Lin
Wenfang B. Fang
Qing Ma
Gerald Friedland

Background This study was conducted to examine the pharmacokinetic interactions between buprenorphine/naloxone (BUP/NLX) and lopinavir/ritonavir (LPV/r) in HIV-seronegative subjects chronically maintained on BUP/NLX.

Keywords:

Buprenorphine
Lopinavir/ritonavir
Virology
Ritonavir
Buprenorphine/naloxone
ANTIRETROVIRAL AGENTS
Lopinavir
NLX
Pharmacology
Medicine
Pharmacokinetics
Anesthesia
once daily

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations